Related Experiment Videos
Osteoblast stimulation in multiple myeloma lacking lytic bone lesions
R Bataille1, D Chappard, C Marcelli
1INSERM U291, Centre Gui-de-Chauliac, Hôpital Saint-Eloi, Montpellier, France.
British Journal of Haematology
|December 1, 1990
Summary
Some multiple myeloma (MM) patients avoid bone loss due to stimulated osteoblastic activity, unlike typical lytic lesions. This cellular finding links to sclerotic MM variants, particularly IgG lambda subtypes.
Area of Science:
- Oncology
- Bone Biology
- Hematology
Background:
- Multiple myeloma (MM) often causes severe bone loss and lytic lesions.
- The mechanisms protecting some MM patients from bone degradation are not fully understood.
Purpose of the Study:
- To investigate the cellular and tissue-level bone conditions in MM patients who do not develop lytic bone lesions.
- To identify factors associated with preserved bone integrity or sclerotic lesions in MM.
Main Methods:
- Histological evaluation and quantitative bone histomorphometry of bone biopsies from 10 MM patients without lytic lesions.
- Analysis of serum bone gla protein levels.
- Correlation with immunoglobulin subtype (IgG, IgA, kappa, lambda).
Main Results:
- All 10 patients exhibited significantly increased osteoblastic activity.
- Seven patients showed increased bone resorption alongside increased osteoblastic activity; three had a pure osteoblastic presentation.
- Elevated serum bone gla protein levels were observed in most patients with increased osteoblastic activity.
- 90% of these patients had lambda MM, with 70% being IgG lambda MM, an association with sclerotic variants.
Conclusions:
- A subset of multiple myeloma patients maintain bone health due to stimulated osteoblastic activity.
- This osteoblastic stimulation is characteristic of patients who do not develop severe bone loss or exhibit sclerotic lesions.
- These findings suggest a link between osteoblastic activity, specific MM subtypes (IgG lambda), and resistance to bone degradation.